Roche has reported a 5 percent rise in sales for the first quarter of 2013, boosted by strong demand for Tamiflu
Total sales hit 11.6 billionn Swiss francs ($12.4 billion) in the first three months of 2013.
Roche has reported a 5 percent rise in sales for the first quarter of 2013, boosted by strong demand for Tamiflu
Tamiflu sales rose during a heavy flu season in the US, and there was also strong demand for Roche’s cancer drugs.
“We got off to a very good start in 2013 due to strong organic growth,” said Roche chief executive Severin Schwan.
During the first quarter of 2013, the Basel-based company launched two new drugs to fight breast cancer, Kadcyla in the US and Perjeta in Europe.
Roche expects its full-year total sales to grow at much the same rate as 2012, when they rose by 7%. Roche also said it expected to increase its share dividend this year.
“Based on the first quarter results, I am confident we will meet our full-year targets,” Severin Schwan said.
Quincy Jones, the celebrated musician and producer who worked with Michael Jackson, Frank Sinatra, Ray…
Misleading allegations, rumours and outright lies about voting and fraud are flooding online spaces in…
At least 158 people have died in Spain's worst flooding disaster in generations. On October…
Google has been fined two undecillion (a two followed by 36 zeroes) roubles by a…
Embarking on a home remodel is an exciting journey, promising enhanced comfort, increased property value,…
The US presidential candidates continued to campaign across key swing states on October 20. Footage…
